Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acer Therapeutics Inc (NASDAQ:ACER)

17.81
Delayed Data
As of Oct 20
 +0.0034 / +0.02%
Today’s Change
5.18
Today|||52-Week Range
37.75
+86.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues726.3K726.3K0.000.00
 
 
 
Depreciation And Amortization52.0K47.8K0.000.00
 
 
 
 
Operating ExpensesGross Income----0.000.00--
General Expenses2.7M1.4M925.9K677.9K
 
 
 
 
 
Research And Development2.2M687.8K206.0K-796.00
 
 
 
 
 
Total Operating Expenses2.7M1.4M925.9K677.9K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.0M-678.1K-925.9K-677.9K
 
 
 
 
 
Interest Expense On Debt224.00961.001.2K614.00
 
 
 
 
 
Other Expenses-2.4K5.8K467.00-26.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.0M-1.7M-926.3K-678.2K
 
 
 
 
 
Net Income-2.0M-1.7M-926.3K-678.2K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS683.1K689.6K733.7K739.4K
 
 
 
 
 
Shares To Calculate EPS Diluted683.1K689.6K733.7K739.4K
 
 
 
 
 
 
Earnings Per ShareEPS-$2.90-$2.49-$1.24-$0.93
 
 
 
 
 
EPS Diluted-$2.90-$2.49-$1.24-$0.93